NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

顯示第 33 至 48 項結果，共 50 項

• 

  查看內容

  Anti-IL-6 receptor [rhPM-1 (Tocilizumab)] (Ab00737-10.3-BT)

• 

  查看內容

  Anti-IL-6 receptor [rhPM-1 (Tocilizumab)] (Ab00737-10.3)

• 

  查看內容

  Anti-Integrin alpha 4 [Natalizumab] (Ab00716-13.0-BT)

• 

  查看內容

  Anti-Integrin alpha 4 [Natalizumab] (Ab00716-13.0)

• 

  查看內容

  Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.3-BT)

• 

  查看內容

  Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.3)

• 

  查看內容

  Anti-TNF alpha [CDP 571 (Humicade)] (Ab00448-13.0-BT)

• 

  查看內容

  Anti-TNF alpha [CDP 571 (Humicade)] (Ab00448-13.0)

• 

  查看內容

  Anti-TNF alpha [D2E7 (Adalimumab)] (Ab00718-10.0-BT)

• 

  查看內容

  Anti-TNF alpha [D2E7 (Adalimumab)] (Ab00718-10.0)

• 

  查看內容

  Anti-TNF alpha [D2E7 (Adalimumab)] (Ab00718-10.3-BT)

• 

  查看內容

  Anti-TNF alpha [D2E7 (Adalimumab)] (Ab00718-10.3)

• 

  查看內容

  Anti-Tumor associated glycoprotein (TAG) 72 [B72.3 (Satumomab)] (Ab00280-1.1-BT)

• 

  查看內容

  Anti-Tumor associated glycoprotein (TAG) 72 [B72.3 (Satumomab)] (Ab00280-1.1)

• 

  查看內容

  Anti-VEGF [Bevacizumab] (Ab00715-10.0-BT)

• 

  查看內容

  Anti-VEGF [Bevacizumab] (Ab00715-10.0)